Insights on Life Sciences


Innovation sourcing in biopharma: Four practices to maximize success

– Biopharma companies’ pipelines are full of assets they source externally to access innovation. Four practices will help ensure their investments flourish at a time of fierce competition.

A biotech survival kit for a challenging public-market environment

– After a decade of plenty, biotechs are grappling with a challenging market. To emerge strongly, they can streamline R&D and... G&A expenses, evaluate new financing options, and consider mergers with other biotechs.

Three imperatives for R&D in biosimilars

– The biosimilars market is poised to grow over the next decade. Here’s how companies can accelerate time to market, reduce... R&D costs, and improve productivity.

Vision 2028: How China could impact the global biopharma industry

– China-originated biopharmas will likely have greater influence on the industry by 2028, but regulatory developments and the quality... of partnerships will determine how the industry grows.

Developing pharmaceutical launch leaders and company-wide capabilities at scale

– By building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but... also strengthen their organizations for the future.

Five ways that life science companies can build tech talent

– For life science companies to meet their digital ambitions, they must strengthen their technology skills. In a challenging market,... the industry is uniquely positioned to shine.

Advancing real-world evidence for pharmaceutical companies in Japan

– Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better... ensure patient outcomes.

Advanced tech elevates process modeling in batch-processing industries

– In high-volume batch-processing industries, reliable models of manufacturing processes can help companies cut production costs... while improving quality and performance.

What are the biotech investment themes that will shape the industry?

– From 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could... transform the industry.

Special collection

Future of pharma operations

Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations. Contact us to learn more.

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.

The rise of health technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Life Sciences?

More insights


Eight imperatives for launching cell and gene therapies

– Companies launching new cell and gene therapies can live up to their promise of transforming patient lives through proper preparation... of the market, their products, and internal go-to-market models.

Out of the shadows: A brighter future for pharma technical development

– The sometimes-overlooked function of chemistry, manufacturing, and controls (CMC) has a rare opportunity to reimagine its role... and find innovative ways to improve and accelerate drug development.

Against the odds: How life sciences companies excel in large transformations

– Life sciences companies pursuing a step change in performance have obtained mixed results. Adhering to five principles can greatly... improve the odds of a large transformation program succeeding.

India as a pharma innovation hub: An interview with Dr. Reddy’s G. V. Prasad

– The cochairman and managing director of the pharma multinational believes India’s competence in new biology, clinical development,... and chemistry will increase its global competitiveness.

Self-learning: The dawn of a new biomedical R&D paradigm

– Science and technology are driving breakthroughs at each stage of the biomedical R&D value chain. Enhancing feedback loops... among them could unleash a self-learning model that would benefit patients.

‘We want to build the healthcare ecosystem of choice’

– Over the last three years, the Zur Rose Group has been undergoing a transformation to become a true digital company. Walter Hess,... the new CEO of the group, which operates healthcare platforms and online pharma¬≠cies—among them DocMorris—explains in our interview what he has learned along the way.

CROs and biotech companies: Fine-tuning the partnership

– Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations... (CROs). How can CROs raise their game with this key segment?

How digital helps a life sciences leader move at light speed

– Pfizer’s Chief Digital and Technology Officer explains how digital is transforming her organization’s ability to bring... new medicines to patients at speed and at scale.
Podcast - McKinsey Global Institute

Forward Thinking on trade, vaccines, and sustainable and inclusive growth with WTO Director-General Ngozi Okonjo-Iweala

– The World Trade Organization’s first African—and first female—director-general reflects on the impact of the... pandemic on trade, the imperative to ensure that vaccines reach Africa and other emerging economies, and how to ensure that trade is more inclusive in the years ahead.

How biotechs can rethink their strategies after the market downturn

– Biotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash... management and financing and rethinking paths to long-term value creation.

Accelerating growth in medtech: The next surge in portfolio moves

– Large medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the... trajectory?
Sorry, we couldn't find any results. Try removing some filters.

Connect with our Life Sciences Practice